Product
QLS31903
1 clinical trial
1 indication
Indication
CancerClinical trial
A Phase 1 Study to Investigate the Safety, Tolerability，Pharmacokinetics, Immunogenicity and Preliminary Effectiveness of QLS31903 Injection in Subjects With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-06-15